Bouygues Telecom has turned to the French competition authority asking it to overturn the extension of rival Free Mobile’s domestic roaming contract with Orange. L’Express reports that Bouygues Telecom filed a complaint in late July with the Competition Authority, after Free and Orange announced in June an extension of the contract to 2020.
The new agreement with Free and Orange outlines how Free will phase out roaming on Orange’s network, in response to a demand from the telecom regulator Arcep that the operators reduce their reliance on roaming and focus more on network build-out.
Bouygues has repeatedly sought limits on Free’s roaming and called for compensation for the damages it’s suffered since the fourth operator entered the market in 2012. Bouygues claims that by allowing Free to rely on roaming, the fourth operator had a cost advantage over rivals which had to invest in their own networks.
Free’s original agreement with Orange was planned to stop at the end of 2018. Under the new agreement it will gradually lower 3G speeds for customers roaming. Clients were already informed that from 01 September this year roaming speeds will be limited to 5 Mbps download and 448 Kbps upload, and the download speed will drop to 1 Mbps from next January and to 384 Kbps from 2018.
Full Content: Telecompaper
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas